Abstract
Postsynaptic dopaminergic behavioural effects of D-2 agonists can be promoted by concomitant D-1 receptor activation. The present experiment explored whether such effects could be elicited by the putative autoreceptor-selective D-2 agonist B-HT 920, when combined with the D-1 agonist SK&F 38393. Except for occasional jerks induced by B-HT 920, neither agonist caused significant dopaminergic stimulation when given separately, whereas combined treatment with SK&F 38393 and B-HT 920 induced clear-cut motor activation — particularly focused stereotyped licking and sniffing — in reserpine/AMT-pretreated rats. Both the D-1 antagonist SCH 23390 and the D-2 antagonist spiperone abolished these effects, while the SK&F/B-HT-induced stimulation was not significantly affected by the alpha2-blocker idazoxan. It appears that classical postsynaptic DA receptor-stimulatory properties of B-HT 920 can indeed be demonstrated, provided that sufficient D-1 receptor tone prevails.
This is a preview of subscription content, log in via an institution to check access.
References
Andén N-E, Nilsson H, Ros E, Thornström U (1983) Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain. Acta Pharmacol Toxicol 52:51–56
Arnt J (1985) Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal animals. Eur J Pharmacol 113:79–88
Arnt J (1987) Behavioral studies of dopamine receptors: Evidence for regional selectivity and receptor multiplicity. Thesis; Dept. of Pharmacology, H. Lundbeck A/S, Copenhagen, Denmark, pp 1–83
Braun AR, Chase TN (1986) Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131:301–306
Clark D, Hjorth S, Carlsson A (1985) Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J Neural Transm 62:171–207
Grabowska-Andén, Andén N-E (1983) Stimulation of postsynaptic DA2 receptors produces jerks in reserpine-treated rats. J Pharm Pharmacol 35:543–545
Hinzen D, Hornykiewicz O, Kobinger W, Pichler L, Pifl C, Schingnitz G (1986) The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. Eur J Pharmacol 131:75–86
Jennewein HM, Bruckwick EA, Hanbauer I, Mierau J, Lovenberg W (1986) Evidence for a specific effect of BHT 920, an azepine derivative, on tyrosine hydroxylation in the dopaminergic system of the rat. Eur J Pharmacol 123:363–369
Setler PE, Sarau HM, Zirkle CL, Saunders HL (1978) The central effects of a novel dopamine agonist. Eur J Pharmacol 50:419–430
Stoof JC, Kebabian JW (1984) Two dopamine receptors: Biochemistry, physiology and pharmacology. Life Sci 35:2281–2296
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hjorth, S., Carlsson, A. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393. Psychopharmacology 93, 534–537 (1987). https://doi.org/10.1007/BF00207249
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00207249